Susan Kelly and Elise Reuter

BioTech

CDRH Director Shuren to step down after 15 years

Jeff Shuren, who leads the Food and Drug Administration’s medical devices unit, will step down after 15 years as director. Michelle Tarver, deputy director for

Susan Kelly and Elise Reuter July 24, 2024

BioTech

FDA’s lab developed test rule could be first check on agency’s power post-Chevron

The recent landmark U.S. Supreme Court decision to overturn the Chevron doctrine could open the door to more challenges of Food and Drug Administration regulations,

Susan Kelly and Elise Reuter July 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Susan Kelly and Elise Reuter

CDRH Director Shuren to step down after 15 years

FDA’s lab developed test rule could be first check on agency’s power post-Chevron

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe